Novel RSV Vaccine Offers Strong Protection Against Serious Respiratory Illness
In a phase 3 RENOIR trial, a novel RSV vaccine demonstrated robust protection against serious respiratory illness.
In a phase 3 RENOIR trial, a novel RSV vaccine demonstrated robust protection against serious respiratory illness.